Drugs / Babaodan Capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06371196 | Apr 2024 → Jul 2025 | primary biliary cholangitis | Mei Han | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Babaodan Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06371196 ↗ |
| Route | Oral | “2 capsules / times, tid, oral” NCT06371196 ↗ |